These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 4981797)

  • 1. Two anticomplementary factors in cobra venom: hemolysis of guinea pig erythrocytes by one of them.
    Ballow M; Cochrane CG
    J Immunol; 1969 Nov; 103(5):944-52. PubMed ID: 4981797
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation of the anticomplementary protein from cobra venom and its mode of action on C3.
    Müller-Eberhard HJ; Fjellström KE
    J Immunol; 1971 Dec; 107(6):1666-72. PubMed ID: 5120401
    [No Abstract]   [Full Text] [Related]  

  • 3. Bypass-activation of the complement system starting with C3. I. Generation and function of an enzyme from a factor of guinea-pig serum and cobra venom.
    Bitter-Suermann D; Dierich M; König W; Hadding U
    Immunology; 1972 Sep; 23(3):267-81. PubMed ID: 4214761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum proteins involved in decay and regeneration of cobra venom factor-dependent complement activation.
    Fearon DT; Austen KF; Ruddy S
    J Immunol; 1973 Dec; 111(6):1730-6. PubMed ID: 4796101
    [No Abstract]   [Full Text] [Related]  

  • 5. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions.
    Cochrane CG; Müller-Eberhard HJ; Aikin BS
    J Immunol; 1970 Jul; 105(1):55-69. PubMed ID: 4246566
    [No Abstract]   [Full Text] [Related]  

  • 6. Blocking of the hemolytic expression of the classical complement sequence by products of complement activation via the alternate pathway. Materials responsible for the blocking phenomenon and their proposed mechanism of action.
    Koethe SM; Austen KF; Gigli I
    J Immunol; 1973 Feb; 110(2):390-400. PubMed ID: 4684033
    [No Abstract]   [Full Text] [Related]  

  • 7. Production of antibodies monospecifically reactive with the third component of guinea pig complement.
    Burkholder PM
    Int Arch Allergy Appl Immunol; 1970; 37(2):124-42. PubMed ID: 5411244
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune hemolysis and a basic peptide from cobra venom.
    Okada H; Campbell W
    J Immunol; 1974 Nov; 113(5):1647-9. PubMed ID: 4472944
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on eosinophil leucocyte migration. II. Factors specifically chemotactic for eosinophils and neutrophils generated from guinea-pig serum by antigen-antibody complexes.
    Kay AB
    Clin Exp Immunol; 1970 Nov; 7(5):723-37. PubMed ID: 4992784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation and function of a complement-activating enzyme generated from factors of guinea pig serum and cobra venom.
    Dierich MP; Bitter-Suermann D; König W; Hadding U
    Eur J Immunol; 1971 Aug; 1(4):309-11. PubMed ID: 5157967
    [No Abstract]   [Full Text] [Related]  

  • 11. Separation of different serological activities associated with immunoglobulins from sera of rabbits immunized with rat erythrocytes.
    Kastelan M; Vitale L; Vitale B
    Eur J Immunol; 1971 Nov; 1(5):363-6. PubMed ID: 5003356
    [No Abstract]   [Full Text] [Related]  

  • 12. Interaction of C-reactive protein complexes with the complement system. II. Consumption of guinea pig complement by CRP complexes: requirement for human C1q.
    Volanakis JE; Kaplan MH
    J Immunol; 1974 Jul; 113(1):9-17. PubMed ID: 4208926
    [No Abstract]   [Full Text] [Related]  

  • 13. Activation of complement by endotoxin: a role for 2 globulin, C1, C4 and C2 in the consumption of terminal complement components by endotoxin-coated erythrocytes.
    Phillips JK; Snyderman R; Mergenhagen SE
    J Immunol; 1972 Aug; 109(2):334-41. PubMed ID: 4114826
    [No Abstract]   [Full Text] [Related]  

  • 14. In vivo abrogation of serum C3 and C5 by administration of cobra venom factor and heterologous anti-C3.
    Drake WP; Pokorney DR; Mardiney MR
    J Immunol Methods; 1974 Dec; 6(1-2):61-72. PubMed ID: 4215835
    [No Abstract]   [Full Text] [Related]  

  • 15. Physicochemical characterization of the fifth (C5), sixth (C6), seventh (C7), eighth (C8) and ninth (C9) component of guinea pig complement.
    König W; Bitter-Suermann D; Dierich M; Hadding U
    Eur J Immunol; 1971 Nov; 1(5):372-6. PubMed ID: 5157761
    [No Abstract]   [Full Text] [Related]  

  • 16. The structure and function of the third component of guinea pig complement. I. The effect of chemical reagents on immune hemolysis and immune adherence reactivity.
    Okuda T
    Immunochemistry; 1973 Jun; 10(6):373-9. PubMed ID: 4738908
    [No Abstract]   [Full Text] [Related]  

  • 17. HAEMOLYTIC ACTION OF COBRA VENOM LECITHINASE-A IN THE PRESENCE OF WHOLE GUINEA-PIG SERUM OR LECITHIN.
    VAN OSSC ; GOETZE O
    Z Immunitats Allergieforsch; 1963 May; 125():75-9. PubMed ID: 14048618
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative hemolysis experiments on guinea pig and rat erythrocytes in vitro with phospholipase A and direct lytic factor from cobra (Naja naja) venom].
    Oldigs HD; Lege L; Lankisch PG
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(1):27-32. PubMed ID: 4250101
    [No Abstract]   [Full Text] [Related]  

  • 19. The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.
    Brade V; Nicholson A; Lee GD; Mayer MM
    J Immunol; 1974 May; 112(5):1845-54. PubMed ID: 4818461
    [No Abstract]   [Full Text] [Related]  

  • 20. The immune response in the hamster. V. Biologic activities of 7S-gamma-1 and 7S-gamma-2 globulins.
    Coe J; Peel L; Smith RF
    J Immunol; 1971 Jul; 107(1):76-82. PubMed ID: 4997117
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.